1
INTRODUCTION 17
Prostaglandins are 20-carbon fatty acid signalling molecules that are released by 18 diverse cells types, including adipocytes 1-3 . PGF 2α and PGE 2 bind to their respective 19 cell surface G protein-coupled receptors and activate a variety of downstream signalling 20 events. Although PGF 2α and PGE 2 are stable in plasma at 37˚C, they do not function as 21 circulating hormones. Rather, they are taken up by the broadly expressed prostaglandin 22 reuptake carrier PGT (SLCO2a1) and delivered to a cytoplasmic oxidase for enzymatic 23 oxidative inactivation 4,5 . PGT is the rate-limiting step in this two-step inactivation 6 . The 24 affinities of PGF 2α and PGE 2 for their cognate receptors and for PGT are similar; 25 because they compete for ligand, altering the rate of PGF 2α and PGE 2 uptake by PGT 26 reciprocally alters the degree of receptor signalling 7 . 27 PGF 2α and PGE 2 modulate adipose biology. In white adipose tissue (WAT), 28 PGF 2α binds to its Gq-coupled receptor (FP) on adipocyte precursor cells, inhibiting 29 adipocyte differentiation and lipogenesis 8 . This effect is evident in humans when topical 30 therapeutic PGF 2α analogues shrink the size of periorbital fat pads 9 . Conversely, mice 31 lacking PGF 2α synthase exhibit increased body fat on both normal and high fat diets 10 . 32
In contrast, PGE 2 appears to play a role primarily in inducing beige fat. When 33 cold exposure stimulates sympathetic nervous outflow, the resulting activation of 34 adipocyte adrenergic receptors by norepinephrine stimulates white adipocytes to 35 synthesize PGE 2 . The latter enhances beige conversion and expression of uncoupling 36 protein 1 (UCP1), thereby amplifying the cold response [11] [12] [13] [14] . 37
Based on these effects of PGF 2α and PGE 2 on adipocyte biology, we 38 hypothesized that genetically deleting PGT globally in mice ("PGT-KO") would increase 39 both systemic PGE 2 and PGF 2α , resulting in UCP1 induction and a lean phenotype. We 40 found that, although PGT-KO mice are lean due to beige transformation of iWAT and 41 thermogenesis, these processes are induced at thermoneutrality and do not require 42 UCP1. Indeed, UCP1 knockout mice develop comparable iWAT beige transformation 43 and thermogenesis when PGT is blocked pharmacologically. Suppression of UCP1 in 44 PG-KO mice is secondary to suppression of PPARγ by FP receptor activation. The 45 findings suggest that targeting PGT therapeutically may offer a novel approach for 46 inducing a lean phenotype without UCP1. 47 or intestinal integrity ( Supplementary Figure 2) , indicating that neither reduced energy 71 intake nor malabsorption was not the cause of the lean phenotype. Because PGT-KO 72 mice are lean despite a higher energy intake, they must be dissipating the excess 73 energy as work and/or heat 15 . Infrared beam interruption assay revealed an increase 74 only of Y axis activity in PGT-KO mice, which was clustered at the onset of the active 75 phase, a pattern indicative of hunger ( Figure 2B ) 16 . PGT-KO mice exhibited an increase 76 in O 2 consumption (VO 2 ) per lean body mass by indirect calorimetry ( Figure 2C ); under 77 these experimental conditions, the observed change in VO 2 cannot be attributed to the 78 small increase in activity 17 . To assess which tissues account for the whole-animal 79 increase in thermogenesis, we injected mice with tracer deoxyglucose (F-18 FDG) and 80
harvested tissues for analysis of uptake. Neither skeletal muscle nor interscapular 81 brown adipose tissue (iBAT) displayed increased glucose uptake ( Figure 2D ). Further 82 examination of skeletal muscle revealed no evidence for mitochondrial expansion or 83 enhanced VO 2 ( Supplementary Figure 2) . In contrast, iWAT exhibited a significant 84 increase in F-18 FDG uptake ( Figure 2D ). Moreover, iWAT tissue explants from PGT-85 KO mice appeared visually "browned" (Supplementary Figure 2) . PGT-KO iWAT 86 exhibited induction of mitochondrial citrate synthase activity ( Figure 2E ), of browning 87 genes (except UCP1) ( Figure 2F ), and of VO 2 ( Figure 2G ). Extrapolating citrate 88 synthase activity and VO 2 of iWAT explants to the entire iWAT fat pad, or to the whole 89 mouse, revealed a significant thermogenic capacity of this depot in PGT-KO mice 90 ( Figure 2E ,G), a finding in agreement with the F-18 FDG results. Comparable 91 extrapolations using liver citrate synthase data were unremarkable (Supplementary 92 Figure 2 ). 93
WAT beige induction in PGT-KO mice represents "primary browning" 94
Skin or tail disorders in mice housed at ambient temperature can cause heat 95 loss, resulting in "secondary browning" of WAT 18 . To address secondary browning as 96 phenotypic driver in PGT-KO mice, animals were tested in a water repulsion assay that 97 detects heat loss from skin disorders 19 . PGT-KO mice retained less water after 98 immersion and defended body temperature as well as control mice (Supplementary 99 Figure 3 ). To further exclude secondary browning, we constructed a thermal preference 100 assay in which mice can choose freely amongst cages held at 22ºC, 27ºC, or 32ºC 101 (Supplementary Figure 3 ) 20 . We validated the assay by determining the shift in thermal 102 preference of C57BL/6J mice before and after depilation, which induces heat loss 21 ; fur 103 removal induced a large shift in preference to 32ºC ( Supplementary Figure 3 ). PGT wild 104 type mice housed at 22ºC and then assessed over 24 hours in the preference assay 105 demonstrated an integrated preference for the 32ºC cage, whereas similarly housed 106 and assayed PGT-KO mice displayed a preference distribution that was shifted toward 107 cooler cages; these behaviours were more pronounced during the inactive (light) phase 108 than the active (dark) phase ( Figure 3A ). Housing mice at 32˚C before subjecting them 109 to the thermal preference assay shifted all mice toward a warmer preference in the 110 assay compared to those housed at 22ºC; nonetheless, the population time budget 111 distribution for PGT-KO mice compared to wild type controls remained shifted overall 112 toward a cooler preference ( Figure 3B ). 113
As with mice housed at 22ºC, PGT-KO mice housed for 1 month at 114 thermoneutrality (30ºC) displayed increased thermogenesis compared to control mice 115 Figure 3 ). Core body temperature of PGT-KO mice 116 housed at 30ºC was higher than that of control mice during the inactive and late active 117 phases ( Figure 3D ). In contrast, core body temperature of PGT-KO mice housed at 118 22ºC was not different from that of control mice ( Figure 3E ). That PGT-KO mice 119 dissipate their incremental heat when housed at 22ºC, but not at 30ºC, indicates that 120 they have hyperthermia, rather than fever 18 . In accord with hyperthermia, PGT-KO mice 121 housed at 30ºC displayed reduced spontaneous activity compared to mice housed at 122 22ºC (compare Figure 3F to Figure 2B ). Scholander analysis 22 failed to indicate heat 123 loss in PGT-KO mice, i.e. there was no differential increase in VO 2 of PGT-KO mice 124 upon reducing environmental temperature 23 ; rather, PGT-KO mice exhibited an 125 increase in VO 2 only at thermoneutrality ( Figure 3G ). To test further the hypothesis that 126
(Figures 3C and Supplementary
PGT-KO mice housed at 30ºC are thermogenic, we transferred wild type control and 127 PGT-KO mice from 30ºC housing acutely to 4ºC. Control mice defended core body 128 temperature poorly and engaged in shivering, as determined by leak of muscle creatine 129 kinase 24 , whereas PGT-KO mice were able to defend body temperature with no 130 apparent shivering ( Supplementary Figure 3) . 131
WAT beige induction in PGT-KO mice persists on high-fat diet 132
To render these results more translatable to human obesity 25 , we fed mice 133 housed at 30ºC a 60% high fat diet (HFD) for 1 month. The lean phenotype persisted 134 under these conditions, with a reduction in body weight and total body fat and an 135 increase in VO 2 per lean body mass ( Supplementary Figure 3) . Explants of iWAT from 136 PGT-KO mice revealed increased O2 consumption compared to controls 137 (Supplementary Figure 3) . Finally, analysis of WAT gene expression revealed an 138 increase in brown and beige markers in iWAT, but not gWAT, of PGT-KO mice housed 139 at 30˚C on HFD ( Supplementary Figure 3) . 140
Inhibiting PGT pharmacologically reproduces the knockout phenotype 141
To avoid possible confounding effects of altered adipose development when PGT 142 is deleted from the single cell stage onward, as in PGT-KO mice, and to test whether 143 inhibiting PGT on a pure C57BL/6 genetic background (as opposed to a mixed 129/BL6 144 genetic background) also results in thermogenesis 26 , we administered a high-affinity 145 PGT inhibitor 27 intraperitoneally to 2 month old C57BL/6J mice for 80-90 days. This 146 phenocopied the results in PGT-KO mice as well as our previous results using a lower-147 affinity PGT inhibitor 28 , producing an increase in urinary PGE 2 and PGF 2α excretion 148 (compare Figure 1A and Supplementary Figure 4 ). In C57BL/6J mice consuming a high 149 fat diet, pharmacological PGT inhibition caused no change in food intake, but reduced 150 body weight gain, a change that was entirely attributable to reduced fat accretion 151 Figure 4A ). Indeed, in mice exposed to 4ºC acutely for 15 hours, UCP1 gene 163 expression in PGT-KO iWAT was suppressed relative to that of WT controls (Figure  164 4B). The lack of engagement of UCP1 in iWAT and iBAT of PGT-KO mice can be 165 appreciated from UCP1 Q-PCR Ct values in these depots; the Ct's were numerically 166 higher (indicating lower mRNA expression) in iWAT and iBAT of PGT-KO mice housed 167 at 22˚C and 30˚C, and in iWAT of mice exposed to 4˚C for 16 hours; the only exception 168 was iBAT of PGT-KO mice after 4ºC exposure (Supplementary Figure 5) . 169
To explore further the concept that inhibiting PGT induces thermogenesis in the 170 absence of UCP1 induction, we assessed the defence of core body temperature in 171 UCP1 knockout mice (UCP1-KO) 29 . We housed UCP1-KO mice 30 at 30ºC, 172 administered vehicle (DMSO) alone, and brought them acutely to 4ºC, whereupon they 173 defended core body temperature poorly, exhibiting a mean drop of core body 174 temperature of ~9ºC over 3 hours ( Figure 4C ). We then administered the PGT inhibitor 175 for 7 days and repeated the assay; the same mice now exhibited improved acute 176 defence of core body temperature, with a mean drop in core body temperature of < 6ºC 177 at 3 hours ( Figure 4C ). Finally, we washed out the inhibitor for 2 weeks; the same mice 178 reverted toward their previous state of impaired defence of core body temperature 179 ( Figure 4C ). Separately, we housed UCP1-KO mice at 30ºC and treated them with 180 vehicle or PGT inhibitor. The inhibitor induced thermogenesis, as judged by indirect 181 calorimetry and induction of the beige genes PGC1α, Cidea, and Dio2 in iWAT ( Figure  182 4D-E). Thus, inhibiting PGT at thermoneutrality induces iWAT-based thermogenesis in 183 the complete absence of UCP1. 184
Factors contributing to suppression of iWAT UCP1 gene expression 185
We explored two possible mechanisms for suppression of UCP1 in PGT-KO 186 mice. First, because PGE 2 is known to act through inhibitory EP 3 receptors on 187 sympathetic nerve endings to reduce norepinephrine release 31-33 , and because PGE 2 is 188 elevated in PGT-KO mice ( Figure 1A ) and in PGT inhibitor-treated mice (Supplementary 189 Figure 4 ), we measured urinary norepinephrine, an index of systemic norepinephrine 190 release from sympathetic nerve terminals [34] [35] [36] . As shown in Figure 5A Despite the loss of norepinephrine as a cyclic AMP agonist, protein kinase A 203 (PKA) activity of PGT-KO iWAT exhibited only a modest reduction ( Figure 5B ). Because 204 PKA in the iWAT depot of sympathectomized mice retains its ability to be activated by 205 agonists 40 , the persistent PKA activity seen here in PGT-KO iWAT suggests that 206 chronically elevated PGE 2 is functioning as a constitutive PKA activator 12 in lieu of the 207 normal facultative adrenergic stimulus. 208
We also tested a second hypothesis, namely that suppression of iWAT UCP1 209 gene expression is intrinsic to the PGT-KO iWAT adipocyte. We isolated the stromal 210 are consistent with a model in which the cAMP pathway in iWAT that is activated by 219 PGE 2 induces PGC1α expression, but the latter is incapable of increasing UCP1 220 transcription because its co-factor PPARγ is suppressed [43] [44] [45] . 221
In considering the mechanism of iWAT PPARγ suppression, we noted reports 222 that PGF 2α , acting through its Gαq-coupled receptor FP, suppresses PPARγ, and hence 223 UCP1, gene expression 3,8,46 . To test the degree to which PGF 2α plays such a role in 224 PGT-KO mice, we administered the specific FP receptor antagonist AL8810 47-49 to WT 225 and PGT-KO mice for 4 days. Figure 5G shows that blocking FP signalling reversed the 226 effects of PGT-KO on iWAT PPARγ, UCP1, and aP2 gene expression, suggesting that 227 the rise in PGF 2α from PGT-KO plays a dominant role in suppressing both iWAT UCP1 228 and the white adipocyte phenotype. 229
Thermogenesis in PGT-KO iWAT is coupled to ATP synthesis and is associated 230 with induction of the creatine shuttle pathway which, in turn, is dependent upon 231 signalling through the PGF 2α receptor 232
Because UCP1 is not induced in PGT-KO iWAT, the incremental thermogenesis 233 is unlikely to be uncoupled from ATP synthesis, as is the case with UCP1-derived 234 thermogenesis. We examined this question directly by determining the O 2 consumption 235 rate of iWAT explants from WT and PGT-KO mice before and after inhibiting ATP 236 synthase with oligomycin. These measurements revealed that the increment in iWAT O 2 237 consumption is coupled to ATP synthesis ( Figure 6A-B ). In addition to the induction of 238 iWAT browning genes in the absence of UCP1 50 , induction of elements of the classical 239 creatine shuttle in this setting have also been reported 24 . Here, iWAT of PGT-KO mice 240 housed at thermoneutrality displayed induction of genes encoding the creatine 241
transporter Slc6a8 and mitochondrial creatine kinases Ckmt1 and Ckmt2 ( Figure 6C ). 242
Inhibiting PGT pharmacologically in C57BL/6 mice housed at 30˚C induced Ckmt1 and 243
Ckmt2 in iWAT ( Figure 6D ). In UCP1-KO mice housed under the same conditions, the 244 PGT inhibitor induced iWAT expression of Ckmt1 and Slc6a8 ( Figure 6E ), indicating 245 that cold exposure of UCP1-KO mice is not required for induction of creatine shuttle 246 components. To test the hypothesis that the creatine pathway contributes to whole-247 mouse thermogenesis in PGT-KO mice, we administered the Slc6a8 transporter 248 inhibitor β-guanidinopropionic acid (β-GPA) systemically as reported 24 , however, we 249 were unable to normalize the augmented VO 2 of PGT-KO mice in this manner 250 (Supplementary Figure 6) . 251
Because the PGF 2α receptor FP plays a key role in suppressing UCP1 gene 252 expression in PGT-KO mice ( Figure 5G ), we also explored the role of FP in control of 253 the creatine shuttle pathway. Administering the FP antagonist AL8810 to PGT-KO mice 254 reversed the induction of iWAT Ckmt1, Ckmt2, and Slc6a8 ( Figure 6F ). In addition to 255 genes of the creatine shuttle, the muscle genes Serca1 (Atp2b1) and Myf5 and were 256 also induced in iWAT of PGT-KO mice, as were a number of genes of fatty acid β-257 oxidation (Supplementary Figure 6) . In contrast, there was no induction of genes 258 involved in either lipolysis or lipogenesis (Supplementary Figure 6) . 259
Thermogenesis in PGT-KO iWAT beige adipocytes is dependent upon creatine 260
To explore further the mechanism of thermogenesis in PGT-KO iWAT, we used 261 adipocytes induced in vitro from the stromal vascular fraction. As with iWAT explants, to activation of the PGF 2α receptor. The incremental respiration is coupled to ATP 280 synthesis ("non-canonical thermogenesis") and is accompanied by induction of the 281 creatine shuttle pathway, which is functionally necessary for the increased respiration. 282
Primary thermogenesis in PGT-KO mice 283
A compelling argument has been adduced that many cases of beige induction in 284 mice housed at ambient temperatures are not primary, but rather are secondary due to 285 heat loss through skin, fur, or tail 18 . We addressed this issue in several complementary 286 ways. First, PGT-KO mice exhibit normal water repulsion and a behavioural preference 287 for a cooler, rather than warmer, environment, especially during the inactive phase. 288
Second, Scholander curves on PGT-KO mice are inconsistent with heat loss. Third, 289
PGT-KO mice housed at thermoneutrality maintain an increase of whole-mouse and 290
iWAT O 2 consumption, as well as induction of browning genes in iWAT. Fourth, the 291 response of core body temperature in PGT-KO mice to changes in ambient temperature 292 indicates that they have hyperthermia, not fever. Finally, the thermogenic pathway 293 activated in PGT-KO mice at 30ºC serves to defend PGT-KO mice from acute cold 294 exposure, obviating the need to shiver. Taken together, the data argue strongly that 295 iWAT beige induction in PGT-KO mice is primary and not secondary. 296
Stimulation of mitochondriogenesis and coupled respiration 297
Recent studies have demonstrated that PGE 2 plays an amplifying role in the so-298 called "canonical", or UCP1-mediated, thermogenic response of WAT to cold exposure 299 11,12 . Specifically, norepinephrine increases cyclic AMP levels directly by activating β3-300 adrenergic receptors, and indirectly by inducing PGE 2 synthesis that, itself, activates the 301 same signalling cascade via EP 4 receptors 12 . By increasing systemic levels of PGE 2 in 302 PGT-KO mice, we hypothesized that the cyclic AMP pathway in mice housed under mild 303 thermal stress (22ºC) would be enhanced. Surprisingly, protein kinase A activity in iWAT 304 of these PGT-KO mice was not increased, rather it was only moderately decreased. 305
One possible explanation for this result is that systemic norepinephrine release, as 306 determined by urinary excretion 34,35 , was markedly suppressed in PGT-KO mice and in 307 mice administered a PGT inhibitor. This result is in accord with the known ability of 308 PGE 2 to suppress norepinephrine release from sympathetic nerve termini via EP 3 309 receptors 31-33 . Together, the data suggest that elevating PGE 2 constitutively by blocking 310 its metabolism directly stimulates the iWAT cAMP -protein kinase A pathway, while at 311 the same time inhibiting facultative activation of this pathway by adrenergic agonists. 312
The net result is constitutive activation of mitochondriogenesis, an increase in coupled 313 respiration, and induction of genes of fatty acid β-oxidation. 314
Constraints on UCP1 gene expression in PGT-KO iWAT 315
Whereas deleting PGT increased the expression of a broad array of iWAT 316 browning genes in mice housed both at 30ºC and 22ºC, Ucp1 gene expression was 317 strongly suppressed, and could not be induced even by 16 hrs of exposure to 4ºC. 318
Although administering exogenous PGE 2 alone to mice induces Ucp1 in WAT 12 , 319 inhibiting PGT increases both PGF 2α and PGE 2 . In WAT, PGF 2α suppresses white 320 ( Supplementary Figure 7) . Despite the relatively low capacity of beige adipocyte 334 mitochondria for ATP synthesis 56 , the significant expansion of mitochondrial mass in 335 iWAT of PGT-KO mice appears sufficient to support an increase in coupled O 2 336 consumption. In this regard, it is noteworthy that both the Scholander curves and the 337 modest increase in core body temperature at thermoneutrality, but not ambient, 338 temperature of PGT-KO mice resemble those of voles bred for high aerobic capacity 339 that have a 7% higher mass-adjusted basal metabolic rate compared to controls 57, 58 . 340
Role of genetic strain and thermoneutrality 341
Although 
Therapeutic implications 391
Although activating UCP1-mediated thermogenesis in humans obesity seems 392 theoretically sound, in practice it has been difficult to activate UCP1 in subjects who are 393 obese or beyond their young adult years, or to translate activation into meaningful 394 weight loss in the target population 73 . Instead, it has been argued that non-canonical 395 thermogenesis is less efficient than UCP1-mediated thermogenesis 74 , and therefore 396 may be a preferable therapeutic pathway to target. The present results provide 397 evidence that pharmacologically inhibiting PGT induces robust WAT non-canonical 398 thermogenesis in mice housed at thermoneutrality and consuming a high fat diet, that is 399 conditions mimicking those of obese human subjects. These findings raise PGT as a 400 promising drug target against obesity. The PGT inhibitor PV-02076 27 was dissolved in DMSO and injected intraperitoneally at 413 a dose of 20 mg/kg, with DMSO as a vehicle control. Mouse tissue was either fixed in 414 10% phosphate buffered formalin followed by 70% ethanol for sectioning and staining 415 with hematoxylin and eosin, or was snap-frozen in liquid nitrogen and stored at -80ºC. 416
Mouse whole blood was collected by retro-orbital bleeding and allowed to coagulate at 417 room temperature. Serum was collected by centrifuging whole blood samples at 5000 x 418 g for 10 minutes. Samples were sent to the University of Cincinnati Mouse Metabolic 419
Phenotype Centre, where serum free fatty acids, adiponectin, leptin levels were 420 measured. Mouse liver triglyceride levels were measured by colorimetric assay 421 according to manufacturer instructions (Cat# 10010303, Cayman Chemical, Ann Arbor, 422
Michigan, USA). For food and water intake measurements, mice were housed 423 individually, and food/water intake was measured daily for one week. Body fat 424 composition was measured by echoMRI (Echo Medical Systems, Houston, Texas). CT 425 studies were performed under isoflurane anaesthesia. Urine PGE 2 and PGF 2α were 426 measured by ELISA (Cayman Chemical); urine for these assays as well as stool for the 427 assays below were collected by housing mice in metabolic cages over 2 weeks and 428 samples were stored at -80ºC. data were collected for one week, 0.4 g/kg β-GPA was given daily by IP injections and 452 calorimetry data were collected for one week. 453
Oral glucose tolerance test: Mice were fasted for 6 hours before injection with 2 g/kg 454 glucose by oral gavage for oral glucose tolerance test (GTT). Blood glucose was 455 measured at 15, 30, 60, 90, and 120 minutes post injection. injected for a final concentration of 10 µg/ml. The seahorse assay cycles were: mix for 3 489 minutes, wait for 2 minutes, measure for 3 minutes, repeated 5 times for baseline 490 measurements before injecting with oligomycin. For muscle and iWAT baseline OCR 491 measurements, we adopted previously established protocols as reported in 78,79 . Briefly, 492 muscle and iWAT were collected after sacrifice and washed with Krebs-Henseleit buffer 493 (KHB) (111 mM NaCl, 4.7 mM KCl, 2 mM MgSO4, 1.2 mM Na2HPO4, 0.5 mM carnitine, 494 2.5 mM glucose and 10 mM sodium pyruvate). Tissue were cut into 5-10 mg pieces and 495 plated individually on XF24 islet capture plates. Digitonin was added to permeabilize the 496 membrane. Basal OCR readings were collected with the following cycles: 10 x 2 min 497 measurements, followed by digitonin injection. Subsequent readings were recorded 498 after 2 min mixing and 2 min rest. All OCR values were normalized to individual tissue 499
weights. 500
Heart rate and arterial blood pressure: Mixed 129/BL6 mice 2 months old were 501 treated with DMSO vehicle or PV-02076 (20 mg/kg body weight) for two weeks. On the 502 day of the experiment, they were anesthetized with isoflurane and mean arterial blood 503 pressure (MAP) and heart rate were determined over 10 minutes by non-invasive tail 504 cuff (Coda monitor, Kent Scientific Corp, Torrington, CT). seahorse experiments, XF24 cell culture microplates were coated with Rat Tail Collagen 507 I (Sigma Cat#C3867) before plating wells with prepared SVF as described previously. 508
On Day 6 of SVF differentiation 50mM of β-GPA or vehicle control were added to the 509 differentiation cocktail. Seahorse assay was run on Day 7. The seahorse assay cycles 510 were: mix for 3 minutes, wait for 2 minutes, measure for 3 minutes, repeated 5 times for 511 baseline measurements. Cells were lysed and protein concentration was measured by 512 DC protein assay (Bio-Rad). OCR values were normalized to protein levels, and 513
baseline OCR values were calculated. 514
RNA expression levels: Total adipose tissue RNA was extracted by RNeasy Lipid 515
Tissue Mini Kit (Qiagen), and SVF RNA was extracted with TRIzol (Thermo Fisher) 516 according to manufacturer instructions. RNA expression levels were measured by qRT-517 PCR with Power SYBR green RNA-to-Ct 1-step kit (thermo fisher/applied biosystems) in 518 60 ng RNA/10 µL reactions. 519
Water repulsion: Water repulsion assay was performed as previously described 19 . 520
Baseline body temperature was measured rectally by probe thermometer (YSI-73ATA). 521
Mice were allowed to swim in 30º C water for 2 minutes before being placed on a paper 522 towel for a few seconds to remove excess water. Mice were placed in clean cage with 523 no bedding at 22˚C, and weight and body temperature were determined every 5 524 minutes for 60 minutes. 525
Thermopreference assay: Thermopreference assay was performed as previously 526 described 20 . Briefly, three 10-gallon water tanks were used to house mice cages and 527 water heater-circulators were used to maintain water bath temperatures at 22ºC, 27ºC, 528 and 32ºC. Cage temperatures were monitored by thermometer. Cages were connected 529 by translucent tubing to allow freedom of movement across cages. Mouse movement 530 was monitored by a time-lapse, infrared flash overhead camera (Bushnell Model# 531 119740). Mice were subjected to 5 days of 2-hour per day training on the bench top by 532 connecting two cages with the same tubing. Training multiple mice together increased 533 subsequent multi-cage exploration by single mice in the apparatus. For a given 534 thermopreference assay, one trained mouse was placed into the cages with food and 535 water in all three cages. Mouse data were collected for 4 days at 3 minute time lapse 536 intervals, and time spent in each cage was calculated. 537
Acute cold exposure assay: Mice housed at 30ºC in individual cages without bedding 538 were brought into a 4ºC environment in the same cages for up to 3 hours with ample 539 food and water. Core body temperature was measured every 15 minutes by rectal 540 probe. After the experiment, mice were placed under warm a heat lamp to recover body 541 temperature quickly and were monitored for 1 hour. 542
Serum Creatine Kinase Activity assay:
To assess muscle activity during cold 543 exposure, we measured serum creatine kinase activity. 100 µl of blood was collected by 544 retro-orbital bleeds before and after acute cold exposure. Blood samples were allowed 545 to coagulate in room temperature for at least 10 minutes before spinning at 5000 x g for 546 Pathology Core. Paraffin fixed slides were heated at 60˚C for 1 hour before dewaxing 559 (xylene 2 x 10min, 100% ethanol 2x2min, 95% ethanol 2x2 min, 80% ethanol 2x2min, 560 70% ethanol 2 x 2 min, 70% ethanol 2 x 2 min, water). After dewaxing, slides were 561 washed in TBS buffer twice for 2 minutes each before blocking endogenous peroxidase 562 activity with 3% hydrogen peroxide for 20 minutes at room temperature. Antigen 563 retrieval using 10 mM pH 6.0 Citrate buffer in steamer was performed for 20 minutes, 564 then slides were cooled at room temperature for 30 minutes. Slides were washed again 565 in TBS twice for 3 minutes each before blocking with 2% BSA for 30 minutes at room 566 temperature. Slides were incubated with primary antibody for 60 minutes at room 567 temperature (Tyrosine Hydroxylase Cat# AB75875, Abcam Cambridge, MA, USA, 568 diluted 1:200), then washed 3 times in TBS before applying secondary antibody for 30 569 minutes at room temperature (Cat# MP-7451, Vector Laboratories, Burlingame, CA, 570 USA). Slides were washed twice for 5 minutes each before applying DAB for 2 minutes. 571
Harris Hematoxylin counterstain was applied for 30 seconds, then the slides were 572 mounted with xylene. cut into small pieces. The cut fat pad was transferred into 1 ml of the mitochondrial 578 homogenization buffer and homogenized for 20 seconds in a bead homogenizer 579 (Benchmark Scientific, Edison, NJ). The homogenized solution was centrifuged at 1000 580
x g for 3 minutes and the supernatant (below the fat layer) was transferred into a fresh 581 tube. The lysate was centrifuged again at 1000 x g for 2 minutes and the supernatant 582 was transferred into another fresh tube to spin at 10,000 x g for 10 minutes. The 583 supernatant was discarded, and the mitochondria pellet was resuspended and washed 584 twice in 1 ml of mitochondrial isolation buffer (10,000 x g for 10 minutes). Finally, the 585 purified mitochondria was resuspended in 50 µl of mitochondrial isolation buffer and 586 kept on ice until used for protein quantification and citrate synthase activity assay 587 according to manufacturer's instructions (Cayman Chem cat#701040). 
